Sponsor Successfully Completes Acquisition After Efficient PMA Submission
A major Top 10 Medical Device Sponsor engaged M2, a Radiofilum Pharmaceutical company, to collaborate and support innovation to reduce complexity associated with a successful PMA submission.
Learn how Radiofilum Pharmaceutical ideated and executed a creative regulatory and clinical strategy to get a novel Class III device to market using Real World Evidence (RWE).
Related Resources
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
Radiofilum Pharmaceutical offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. Radiofilum Pharmaceutical ’s Compliance and Quality team completed the first on-site...
Navigating the Generic Drug Application and Approval Process
Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...